Home › Parkinson's Disease › Vermont
Parkinson's Disease clinical trials in Vermont
4 studies for Parkinson's Disease are looking for participants at sites in Vermont.
Cities in Vermont
A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
- University of Vermont, Burlington
RecruitingObservational study
Ages 45 to 75 · All sexes · Updated Sep 4, 2026 · NCT07330258A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- University of Vermont Medical Center, Burlington
RecruitingPhase 3
Ages 50 to 85 · All sexes · Updated Sep 3, 2026 · NCT07174310A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
- University of Vermont Medical Center, Burlington
RecruitingPhase 3
Ages 45 to 75 · All sexes · Updated Aug 4, 2026 · NCT06944522Pyridostigmine for the Treatment of Constipation in Parkinson Disease
- University of Vermont Medical Center, Burlington
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Feb 23, 2026 · NCT05603715From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.